The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Impact of Polymer Size and Cleavability on the Intravenous Pharmacokinetics of PEG-Based Hyperbranched Polymers in Rats
Authors
Keywords
-
Journal
Nanomaterials
Volume 10, Issue 12, Pages 2452
Publisher
MDPI AG
Online
2020-12-08
DOI
10.3390/nano10122452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stealth Coating of Nanoparticles in Drug-Delivery Systems
- (2020) See Yee Fam et al. Nanomaterials
- Challenges in nanomedicine clinical translation
- (2020) Josbert M. Metselaar et al. Drug Delivery and Translational Research
- Hyperbranched Poly(2-oxazoline)s and Poly(ethylene glycol): A Structure–Activity Comparison of Biodistribution
- (2020) James Humphries et al. BIOMACROMOLECULES
- PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
- (2019) Zahid Hussain et al. Drug Delivery and Translational Research
- A 30 kDa polyethylene glycol-enfuvirtide complex enhances the exposure of enfuvirtide in lymphatic viral reservoirs in rats
- (2019) Lisa M. Kaminskas et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Local inflammation alters the lung disposition of a drug loaded pegylated liposome after pulmonary dosing to rats
- (2019) Shadabul Haque et al. JOURNAL OF CONTROLLED RELEASE
- Nanocarrier systems assembled from PEGylated hyperbranched poly(arylene oxindole)
- (2019) Al Halifa Soultan et al. EUROPEAN POLYMER JOURNAL
- dendPoint: a web resource for dendrimer pharmacokinetics investigation and prediction
- (2019) Lisa M. Kaminskas et al. Scientific Reports
- Hyperbranched polyglycerol nanostructures for anti-biofouling, multifunctional drug delivery, bioimaging and theranostic applications
- (2019) Mahboobeh Jafari et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the 3 H-labelled structural lipids after pulmonary delivery in rats
- (2018) Shadabul Haque et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
- (2018) Susan Hua et al. Frontiers in Pharmacology
- Designed multifunctional polymeric nanomedicines: long-term biodistribution and tumour accumulation of aptamer-targeted nanomaterials
- (2018) N. L. Fletcher et al. CHEMICAL COMMUNICATIONS
- Nanomedicines: The magic bullets reaching their target?
- (2018) Beat Flühmann et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics
- (2017) Yongmei Zhao et al. MOLECULAR PHARMACEUTICS
- Effects of Surface Charge of Hyperbranched Polymers on Cytotoxicity, Dynamic Cellular Uptake and Localization, Hemotoxicity, and Pharmacokinetics in Mice
- (2017) Liyu Chen et al. MOLECULAR PHARMACEUTICS
- Challenges associated and approaches for successful translation of nanomedicines into commercial products
- (2017) Vivek Agrahari et al. Nanomedicine
- Lymphatic transport and lymph node targeting of methotrexate-conjugated PEGylated dendrimers are enhanced by reducing the length of the drug linker or masking interactions with the injection site
- (2017) Gemma M. Ryan et al. Nanomedicine-Nanotechnology Biology and Medicine
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanomedicines: oversold or underappreciated?
- (2016) Roy van der Meel et al. Expert Opinion on Drug Delivery
- Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications
- (2016) Anisha A. D’souza et al. Expert Opinion on Drug Delivery
- The Pharmacokinetics and Biodistribution of a 64 kDa PolyPEG Star Polymer After Subcutaneous and Pulmonary Administration to Rats
- (2016) Song Yang Khor et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery
- (2016) Nirmal Marasini et al. Nanomedicine
- Challenges of clinical translation in nanomedicine: A qualitative study
- (2016) Priya Satalkar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Multifunctional hyperbranched polymers for CT/19F MRI bimodal molecular imaging
- (2016) Kewei Wang et al. Polymer Chemistry
- Skin toxicity in a patient with ovarian cancer treated with pegylated liposomal doxorubicin: A case report and review of the literature
- (2016) Joanna Kubicka-Wołkowska et al. Oncology Letters
- Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo
- (2015) Qingguo Xu et al. ACS Nano
- pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
- (2015) Douglas E. V. Pires et al. JOURNAL OF MEDICINAL CHEMISTRY
- Methotrexate-Conjugated PEGylated Dendrimers Show Differential Patterns of Deposition and Activity in Tumor-Burdened Lymph Nodes after Intravenous and Subcutaneous Administration in Rats
- (2015) Lisa M. Kaminskas et al. MOLECULAR PHARMACEUTICS
- In vitro metabolism, disposition, preclinical pharmacokinetics and prediction of human pharmacokinetics of DNDI-VL-2098, a potential oral treatment for Visceral Leishmaniasis
- (2014) Rao Mukkavilli et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- PEG-Based Hyperbranched Polymer Theranostics: Optimizing Chemistries for Improved Bioconjugation
- (2014) Aditya Ardana et al. MACROMOLECULES
- Synthesis of a multimodal molecular imaging probe based on a hyperbranched polymer architecture
- (2014) Nathan R. B. Boase et al. Polymer Chemistry
- Doxorubicin-Conjugated PEGylated Dendrimers Show Similar Tumoricidal Activity but Lower Systemic Toxicity When Compared to PEGylated Liposome and Solution Formulations in Mouse and Rat Tumor Models
- (2012) Lisa M. Kaminskas et al. MOLECULAR PHARMACEUTICS
- Comparative pharmacokinetics of PAMAM-OH dendrimers and HPMA copolymers in ovarian tumor-bearing mice
- (2012) S. Sadekar et al. Drug Delivery and Translational Research
- Synthesis of Biocompatible PEG-Based Star Polymers with Cationic and Degradable Core for siRNA Delivery
- (2011) Hong Y. Cho et al. BIOMACROMOLECULES
- Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
- (2011) Carl D. Walkey et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties
- (2011) Lisa M Kaminskas et al. Nanomedicine
- In vivo biodistribution and accumulation of 89Zr in mice
- (2011) Diane S. Abou et al. NUCLEAR MEDICINE AND BIOLOGY
- Capping Methotrexate α-Carboxyl Groups Enhances Systemic Exposure and Retains the Cytotoxicity of Drug Conjugated PEGylated Polylysine Dendrimers
- (2010) Lisa M. Kaminskas et al. MOLECULAR PHARMACEUTICS
- Partly-PEGylated Poly-L-lysine Dendrimers Have Reduced Plasma Stability and Circulation Times Compared With Fully PEGylated Dendrimers
- (2009) L.M. Kaminskas et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-l-lysine Dendrimers
- (2009) Lisa M. Kaminskas et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles
- (2009) Zhi Yang et al. NANOTECHNOLOGY
- The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Polyl-Lysine Dendrimers
- (2008) Lisa M. Kaminskas et al. MOLECULAR PHARMACEUTICS
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation